Finance

Lists
Why is ATHE up 9,46%?
Dive Deeper
ATHE:NASDAQ
Alterity Therapeutics Ltd
2,43 US$
+9,46%
(+0,21) 1D
6 ნოე, 16:00:01 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ATHE...
Open
2,35 US$
High
2,45 US$
Low
2,35 US$
Mkt. cap
50,07 მლნ.
Avg. vol.
164,14 ათ.
Volume
13,38 ათ.
52-wk high
5,89 US$
52-wk low
2,02 US$
EPS
-0,92 US$
Beta
0,39
Shares outstanding
19,10 მლნ.
No. of employees
11
Open
2,35 US$
High
2,45 US$
Low
2,35 US$
Mkt. cap
50,07 მლნ.
Avg. vol.
164,14 ათ.
Volume
13,38 ათ.
52-wk high
5,89 US$
52-wk low
2,02 US$
EPS
-0,92 US$
Beta
0,39
Shares outstanding
19,10 მლნ.
No. of employees
11
News stories
From web sources and news partners
About Alterity Therapeutics Ltd
CEO-
Employees11
Founded1997
Headquartersმელბურნი, ვიქტორიას შტატი, ავსტრალია
SectorHealth Care
Industry-
Analyst ratings
Based on 3 analysts giving stock ratings to ATHE in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ATHE in the last 3 months.
Highest
Current 2,43 US$
16,00 US$ (+558,44%)
Average
13,67 US$ (+462,55%)
Lowest
10,00 US$ (+311,52%)
Analyst
Recommendation
Action
Price target
Projected
Date
Thomas Flaten
Lake Street
Buy
Maintained
10,00 US$
+311,5%
10/05/2026
Adam Vogel
Craig-Hallum
Buy
Reiterated
15,00 US$
+517,3%
10/05/2026
Debanjana Chatterjee
JonesTrading
Buy
Maintained
16,00 US$
+558,4%
08/28/2026
Caroline Palomeque
Ladenburg Thalmann & Co.
Buy
Initiated
10,00 US$
+311,5%
06/16/2026
Unknown Analyst
Ladenburg Thalmann & Co.
Buy
Initiated
10,00 US$
+311,5%
06/16/2026
Jason McCarthy
Maxim Group
Buy
Reiterated
12,00 US$
+393,8%
06/10/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
1,40 მლნ.
1,40 მლნ.
403,29 ათ.
403,29 ათ.
Cost of goods sold
49,43 ათ.
49,43 ათ.
81,96 ათ.
81,96 ათ.
Cost of revenue
49,43 ათ.
49,43 ათ.
81,96 ათ.
81,96 ათ.
Research and development expenses
3,92 მლნ.
3,92 მლნ.
4,89 მლნ.
4,89 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,56 მლნ.
2,56 მლნ.
2,71 მლნ.
2,71 მლნ.
Operating expense
6,57 მლნ.
6,57 მლნ.
7,65 მლნ.
7,65 მლნ.
Total operating expenses
6,62 მლნ.
6,62 მლნ.
7,73 მლნ.
7,73 მლნ.
Operating income
-5,22 მლნ.
-5,22 მლნ.
-7,32 მლნ.
-7,32 მლნ.
Other non operating income
-
-
-
-
EBT including unusual items
-4,78 მლნ.
-4,78 მლნ.
-6,87 მლნ.
-6,87 მლნ.
EBT excluding unusual items
-4,78 მლნ.
-4,78 მლნ.
-6,87 მლნ.
-6,87 მლნ.
Income tax expense
30,78 ათ.
30,78 ათ.
25,97 ათ.
25,97 ათ.
Effective tax rate
-0,64%
-0,64%
-0,38%
-0,38%
Other operating expenses
95,67 ათ.
95,67 ათ.
46,26 ათ.
46,26 ათ.
Net income
-4,81 მლნ.
-4,81 მლნ.
-6,89 მლნ.
-6,89 მლნ.
Net profit margin
-343,00%
-343,00%
-1 709,06%
-1 709,06%
Earnings per share
-
-
-
-
Interest and investment income
454,88 ათ.
454,88 ათ.
403,45 ათ.
403,45 ათ.
Interest expense
-
-
-
-
Net interest expenses
454,88 ათ.
454,88 ათ.
403,45 ათ.
403,45 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-5,22 მლნ.
-5,22 მლნ.
-7,32 მლნ.
-7,32 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google აპები